• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Intratympanic Drug Therapy Effective for Ménière’s Disease

by David Bronstein • January 15, 2013

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

It also is important to rule out any other causes of dizziness and nerve-related or inner ear hearing loss before jumping to more aggressive therapy with IT medications, Dr. Gurgel said. “We do that by obtaining a baseline MRI to make sure the patient doesn’t have a tumor or other structural anomaly that could be the cause of their balance problems,” he said.

You Might Also Like

  • Intratympanic Corticosteroid Treatment as Effective as Gentamicin for Ménière’s
  • Optimal Usage of Intratympanic Drug Therapy for Sudden Hearing Loss Unclear
  • Endolymphatic Shunt Surgery Comparable to Intratympanic Gentamicin in Controlling Vertigo in Ménière’s Disease
  • IT Steroid Treatment, Oral Corticosteroid Therapy Similar for Sudden Sensorineural Hearing Loss
Explore This Issue
January 2013

Once drug therapy is considered, Dr. Gurgel noted, the frequency of symptoms is an important factor. “If someone is having very active symptoms, IT steroids can help calm down a flare-up,” he said. “But for long-term control, studies have shown that gentamicin is more effective.” In one recent trial of long-term IT gentamicin treatments, the overall rate of successful vertigo control was 92.9 percent at two years of follow-up and 85.7 percent at an average follow-up of 10 years (Acta Otolaryngol. 2009;129:1420-1424).

As with sudden hearing loss, however, the dosage regimens used to treat Ménière’s disease vary considerably both in practice and in the literature, “so there’s not too much guidance there,” Dr. Gurgel said. “We tend to use 40 mg/mL in a single injection, to start.” The difficult question, he pointed out, is when to stop therapy if there is no appreciable response. “There can be diminished effectiveness after two or three injections, although for some patients, more may be warranted.” If there’s no improvement after diet and lifestyle changes, medical therapy and intratympanic injections, he added, “then surgical interventions may be considered.”

Pages: 1 2 | Single Page

Filed Under: Departments, Online Exclusives, Otology/Neurotology, Practice Focus, Special Reports Tagged With: intratympanic drug therapy, Meniere's disease, treatmentIssue: January 2013

You Might Also Like:

  • Intratympanic Corticosteroid Treatment as Effective as Gentamicin for Ménière’s
  • Optimal Usage of Intratympanic Drug Therapy for Sudden Hearing Loss Unclear
  • Endolymphatic Shunt Surgery Comparable to Intratympanic Gentamicin in Controlling Vertigo in Ménière’s Disease
  • IT Steroid Treatment, Oral Corticosteroid Therapy Similar for Sudden Sensorineural Hearing Loss

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939